title: Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems.
abstract: BACKGROUND
  Buprenorphine is an effective treatment for opioid dependence that can be provided in a primary care setting. Offering this treatment may also facilitate the identification and treatment of other chronic medical conditions.
  
  
  METHODS
  We retrospectively reviewed the medical records of 168 patients who presented to a primary care clinic for treatment of opioid dependence and who received a prescription for sublingual buprenorphine within a month of their initial visit.
  
  
  RESULTS
  Of the 168 new patients, 122 (73%) did not report having an established primary care provider at the time of the initial visit. One hundred and twenty-five patients (74%) reported at least one established chronic condition at the initial visit. Of the 215 established diagnoses documented on the initial visit, 146 (68%) were not being actively treated; treatment was initiated for 70 (48%) of these within one year. At least one new chronic medical condition was identified in 47 patients (28%) during the first four months of their care. Treatment was initiated for 39 of the 54 new diagnoses (72%) within the first year.
  
  
  CONCLUSIONS
  Offering treatment for opioid dependence with buprenorphine in a primary care practice is associated with the identification and treatment of other chronic medical conditions.
authors.affiliation: Yale University School of Medicine, New Haven, CT, USA. theresa.rowe@yale.edu
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Rowe
authors.forename: Janet S
authors.initials: JS
authors.lastname: Jacapraro
authors.forename: Darius A
authors.initials: DA
authors.lastname: Rastegar
mesh_terms: D000328:Adult; D002047:Buprenorphine / Q000627:therapeutic use*; D002908:Chronic Disease / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007345:Insurance Claim Review; D008297:Male; D008875:Middle Aged; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011320:Primary Health Care / Q000458:organization & administration*; D012189:Retrospective Studies; D012959:Socioeconomic Factors
chemical_list: D009292:Narcotic Antagonists; D002047:Buprenorphine